Development Agreements in the Health Care Equipment & Supplies Industry
213 Contracts & Agreements
- ACCURAY INC (1 contract)
- Acutus Medical, Inc. (1)
- Apyx Medical Corp (2)
- ARATANA THERAPEUTICS, INC. (4)
- Arno Therapeutics, Inc (1)
- AtriCure, Inc. (2)
- Audentes Therapeutics, Inc. (1)
- Bayhill Therapeutics, Inc. (1)
- BIOCANCELL THERAPEUTICS INC. (2)
- Cardiovascular Systems Inc (2)
- Cascadian Therapeutics, Inc. (1)
- Cell MedX Corp. (2)
- Chelsea Therapeutics International, Ltd. (1)
- Conformis Inc (1)
- CONMED Corporation (1)
- CORNERSTONE THERAPEUTICS INC (6)
- Cynapsus Therapeutics Inc. (1)
- Dare Bioscience, Inc. (1)
- DELCATH SYSTEMS, INC. (1)
- DEXCOM INC (4)
- Durata Therapeutics, Inc. (1)
- ENDOLOGIX INC (11)
- GUIDED THERAPEUTICS INC (1)
- Hancock Jaffe Laboratories, Inc. (1)
- HELIUS MEDICAL TECHNOLOGIES, INC. (1)
- HYPERION THERAPEUTICS INC (1)
- ICU Medical (2)
- IMARX THERAPEUTICS INC (8)
- InspireMD, Inc. (2)
- INSULET CORP (4)
- Insys Therapeutics, Inc. (2)
- INTARCIA THERAPEUTICS, INC (1)
- INTROGEN THERAPEUTICS INC (1)
- LivaNova (1)
- MABVAX THERAPEUTICS HOLDINGS, INC. (1)
- MAGNA LAB INC (2)
- MELINTA THERAPEUTICS, INC. (1)
- Microbot Medical Inc. (1)
- MRI INTERVENTIONS, INC. (8)
- NeuroMetrix, Inc. (2)
- NEUROONE MEDICAL TECHNOLOGIES Corp (5)
- NEVRO CORP (4)
- NOVELION THERAPEUTICS INC. (1)
- NovoCure Ltd (1)
- Orexigen Therapeutics, Inc. (1)
- OSIRIS THERAPEUTICS, INC. (1)
- Outset Medical, Inc. (2)
- Oxford Immunotec Global PLC (1)
- PERNIX THERAPEUTICS HOLDINGS, INC. (1)
- QUIDEL CORP (3)
- Quotient Ltd (5)
- SECOND SIGHT MEDICAL PRODUCTS INC (2)
- Sintx Technologies, Inc. (2)
- Soliton, Inc. (1)
- Stereotaxis, Inc. (5)
- STRATA Skin Sciences, Inc. (1)
- TANDEM DIABETES CARE INC (5)
- Targanta Therapeutics Corp. (3)
- TearLab Corp (3)
- Tobira Therapeutics, Inc. (1)
- TRANSENTERIX INC. (3)
- TREACE MEDICAL CONCEPTS, INC. (1)
- VERMILLION, INC. (3)
- ViewRay, Inc. (68)
- VOLITIONRX LTD (1)
- Zander Therapeutics, Inc (1)
- Amendment No. 1 to the Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care, Inc., dated January 5, 2022 (INSULET CORP, Filed With SEC on February 23, 2024)
- Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care, Inc., dated September 13, 2021 (INSULET CORP, Filed With SEC on February 23, 2024)
- Letter Agreements dated March 18, 2021 between Microbot Medical Ltd. and Technion Research and Development Foundation Ltd (Microbot Medical Inc., Filed With SEC on March 31, 2023)
- Product Development Agreement, dated as of January 2 (Cardiovascular Systems Inc, Filed With SEC on February 9, 2023)
- Amendment No. 3 to Exclusive Development and Distribution Agreement dated as of August 2, 2022 by and between the Company and Zimmer, Inc (NEUROONE MEDICAL TECHNOLOGIES Corp, Filed With SEC on August 11, 2022)
- Amendment No. 2 to Exclusive Development and Distribution Agreement dated as of July 1, 2022 by and between the Company and Zimmer, Inc (NEUROONE MEDICAL TECHNOLOGIES Corp, Filed With SEC on August 11, 2022)
- Amendment No.1 to Development Agreement by and between Insulet Corporation and DexCom, Inc, dated November 21, 2019 (INSULET CORP, Filed With SEC on August 5, 2022)
- Development Agreement by and between Insulet Corporation and DexCom, Inc, dated December 7, 2016 (INSULET CORP, Filed With SEC on August 5, 2022)
- Third Amendment to Exclusive Distribution and Development Agreement (NEUROONE MEDICAL TECHNOLOGIES Corp, Filed With SEC on August 3, 2022)
- Development Agreement, by and between Theravant Corporation and STRATA Skin Sciences, Inc. (attached hereto) (STRATA Skin Sciences, Inc., Filed With SEC on May 11, 2022)
- Development and Supply Agreement, effective April 4, 2022, by and between ViewRay Technologies, Inc. and Siemens Healthcare GmbH (ViewRay, Inc., Filed With SEC on May 6, 2022)
- Construction Agreement dated December 30, 2021 by and between Hanover Development Corporation and Novocure Inc (NovoCure Ltd, Filed With SEC on February 24, 2022)
- Amendment to Exclusive Development and Distribution Agreement by and between the Company and Zimmer, Inc. dated January 6, 2021 (NEUROONE MEDICAL TECHNOLOGIES Corp, Filed With SEC on December 15, 2021)
- Cooperative Research and Development Agreement entered into as of July 8, 2021 between Dare Bioscience, Inc. and the Eunice Kennedy Schriver National Institutes of Child Health... (Dare Bioscience, Inc., Filed With SEC on November 10, 2021)
- Feasibility and Development Agreement, by and between Biotronik SE & Co. KG and Acutus Medical, Inc (Acutus Medical, Inc., Filed With SEC on July 12, 2021)
- Agreement of Joint Research and Development, dated February 17, 2020, by and between Beijing Zhenxigu Medical Research Center (L.P.) and Yubo (English Translation) (MAGNA LAB INC, Filed With SEC on May 6, 2021)
- Form of Product Development Royalty Agreement (TREACE MEDICAL CONCEPTS, INC., Filed With SEC on March 30, 2021)
- Development Agreement, dated November 20, 2020, by and between Tandem Diabetes Care, Inc. and DexCom, Inc (TANDEM DIABETES CARE INC, Filed With SEC on February 24, 2021)
- Agreement of Joint Research and Development, dated February 17, 2020, by and between Beijing Zhenxigu Medical Research Center (L.P.) and Yubo (English Translation) (MAGNA LAB INC, Filed With SEC on January 14, 2021)
- Amendment of Solicitation/Modification of Contract from the Biomedical Advanced Research and Development Authority to Outset Medical, Inc., effective May 9, 2020 (Outset Medical, Inc., Filed With SEC on August 21, 2020)
- Award/Contract from the Biomedical Advanced Research and Development Authority to Outset Medical, Inc., effective September 30, 2019 (Outset Medical, Inc., Filed With SEC on August 21, 2020)
- Marco Dolci Confirmation Letter as SVP Global Operations & Global Research and Development (LivaNova, Filed With SEC on July 29, 2020)
- Exclusive Development and Distribution Agreement dated as of July 20, 2020 by and between NeuroOne and Zimmer (NEUROONE MEDICAL TECHNOLOGIES Corp, Filed With SEC on July 22, 2020)
- Second Amendment to the Assistance Agreement by and between the State of Connecticut, acting by and through the Department of Economic and Community Development and Vermillion,... (VERMILLION, INC., Filed With SEC on April 7, 2020)
- Amendment No. 8 to the Development and Supply Agreement, effective September 19, 2019, by and between ViewRay Incorporated and Siemens Aktiengesellschaft, Healthcare Sector (ViewRay, Inc., Filed With SEC on March 12, 2020)
- Amendment No. 7 to the Development and Supply Agreement, effective November 15, 2015, by and between ViewRay Incorporated and Siemens Aktiengesellschaft, Healthcare Sector (ViewRay, Inc., Filed With SEC on March 12, 2020)
- Cooperative Development Addendum to Engineering and Development Services Master Agreement between Soliton, Inc. and Emphysys, Inc. dated November 20, 2019 (Soliton, Inc., Filed With SEC on November 22, 2019)
- Development Agreement, dated as of September 30, 2019, by and between Howmedica Osteonics Corp. and Conformis, Inc (Conformis Inc, Filed With SEC on November 1, 2019)
- Amendment No.1 to Development and Services Agreement, dated as of December 6, 2018, by and between GSK Consumer Health S.A. and NeuroMetrix, Inc (NeuroMetrix, Inc., Filed With SEC on January 24, 2019)
- Addendum dated August 9, 2018 to the Manufacturing, Supply and Development Agreement by and between TearLab Research, Inc. and MiniFab AB (Aust) Pty Ltd. Dated August 9, 2018.... (TearLab Corp, Filed With SEC on November 8, 2018)
- Manufacturing Supply and Development Agreement by and between TearLab Research, Inc. and MiniFab AB (Aust) Pty Ltd. Dated August 9, 2018. (Portions of this exhibit have been... (TearLab Corp, Filed With SEC on November 8, 2018)
- Development Agreement, dated June 4, 2015 by and between Tandem Diabetes, Care, Inc. and Dexcom, Inc (TANDEM DIABETES CARE INC, Filed With SEC on November 1, 2018)
- COLLABORATIONAND DEVELOPMENT Agreement (Zander Therapeutics, Inc, Filed With SEC on July 10, 2018)
- Eighth Amendment to Development Alliance and Supply Agreement (Stereotaxis, Inc., Filed With SEC on June 25, 2018)
- First Amendment to the Assistance Agreement by and between the State of Connecticut, acting by and through the Department of Economic and Community Development and Vermillion,... (VERMILLION, INC., Filed With SEC on March 13, 2018)
- Development and Services Agreement, dated as of January 12, 2018, by and between Novartis Consumer Health S.A. and NeuroMetrix, Inc (NeuroMetrix, Inc., Filed With SEC on February 8, 2018)
- Product Development Agreement for Ebalance between (Cell MedX Corp., Filed With SEC on January 16, 2018)
- Development and Manufacturing Agreement, dated as of February 1, 2013, by and between the Registrant and Hancock Jaffe Laboratories Aesthetics, Inc (Hancock Jaffe Laboratories, Inc., Filed With SEC on November 6, 2017)
- First Amendment to the Manufacturing and Supply Agreement, dated as of September 30, 2017, by and between the Company and Vention Medical Design and Development, Inc (NEVRO CORP, Filed With SEC on November 6, 2017)
- Third Amendment to the Product Supply and Development Agreement, dated as of September 15, 2017, by and between the Company and EaglePicher Medical Power, LLC (NEVRO CORP, Filed With SEC on November 6, 2017)
